ELAB vs PNR · rev $2.0M vs P/E 18, rev $4.18B
Elevai Labs, Inc. Common Stock (ELAB) versus Pentair PLC (PNR) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Pentair PLC (PNR) is a specialty industrial machinery company listed on NYSE.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported PNR revenue for 2025-12-31 was $4.18B. Net income was $653.8M. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
ELAB currently screens at market cap $6.5M. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
Not investment advice. Open the ELAB and PNR stock pages for the full models.
Not investment advice.